PCM
FMTX

Penserra Capital Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Penserra Capital Management’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,085
Closed -$25K – 1627
2021
Q3 		$25K Buy
1,085
+5
+0.5% +$118 ﹤0.01% 1215
2021
Q2 		$26K Buy
1,080
+70
+7% +$1.88K ﹤0.01% 1112
2021
Q1 		$28K Buy
1,010
+65
+7% +$2.35K ﹤0.01% 912
2020
Q4 		$32K Buy
+945
New +$41.1K ﹤0.01% 767

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Penserra Capital Management's FMTX Position: Q4 2021 in Review

Penserra Capital Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2021, closing a stake of 1,085 shares — an estimated $25K sold.

Penserra Capital Management first reported a position in FMTX in Q4 2020 and held it in 4 quarters. The position peaked at $32K in Q4 2020. 93 funds tracked by Wall St. Rank hold FMTX as of Q4 2021.

  • Penserra Capital Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 1,085 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2021, an estimated $25K.
  • Penserra Capital Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • Penserra Capital Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $32K in Q4 2020.
  • 93 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.